Drug discontinuation: Medroxyprogesterone Acetate Tablet (PROVERA)
FDA lists 2 presentations as To Be Discontinued. Companies: Pfizer Inc..
- Published by source
- 2026-08-31
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Pfizer Inc.
- Products
- Medroxyprogesterone Acetate Tablet PROVERA
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation of the manufacture of the drug; Withdrawal from sale expected September 2026.
- Discontinuation of the manufacture of the drug; Withdrawal from sale expected early October 2026.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-08-31
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #883 | new | 2026-10-22 | 0d37be76dbcb…14753b | b44b2b597af9…34f9ff |
Chain head: #1076 8ad5adc30b9b…88ce20